Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (124)	11/27/2002 1:43:42 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

FHRX Is up 17% on volume of 504K, ahead of its daily average, following on the up-move that started yesterday afternoon.. The insiders hold 35% and had reportedly done some buying. Institutions hold 68%, but had done some selling.<g> The company reported early this month that it broke even in its 3rd Q due to a series of special charges. Without those charges the net would had been around $0.07 siliconinvestor.com The stock is closing its October 4 down draft, and if it can close some of its early July down-gap, it should provide a good % gain from present levels. siliconinvestor.com Bernard

To: Jibacoa who wrote (124)	12/4/2002 1:15:05 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

SQNM Not having, as yet,<g> a significant response to its latest announcement of its Re-Sequencing Technology for SNP discovery application. The stock is up only 2% and volume only 46.7K (about 1/3 of its daily average) The stocks continues to sell around 0.6 of book and below its reported cash/share 0f $2.43 The R/R seems favorable at present levels and IMHO it is worth to continue trying to buy it on any dips, for a possible 200 or 300% gain by the time the tax selling is over and the "January Effect" comes into play next month.<g> bigcharts.marketwatch.com Bernard